TMPRSS2 and neoplasm: GEPIA2 has been explored to dynamically analyze the differential expression of TMPRSS2 in normal and tumor tissues, including RNA sequencing expression data of more than 9,000 tumor samples and more than 8,000 normal samples from TCGA and GTEx.